CN201375702Y - Aorta bypass counter-pulsation heart auxiliary device - Google Patents
Aorta bypass counter-pulsation heart auxiliary device Download PDFInfo
- Publication number
- CN201375702Y CN201375702Y CN200920095633U CN200920095633U CN201375702Y CN 201375702 Y CN201375702 Y CN 201375702Y CN 200920095633 U CN200920095633 U CN 200920095633U CN 200920095633 U CN200920095633 U CN 200920095633U CN 201375702 Y CN201375702 Y CN 201375702Y
- Authority
- CN
- China
- Prior art keywords
- auxiliary device
- inner chamber
- artery
- aorta
- heart auxiliary
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Images
Abstract
The utility model relates to an aorta bypass counter-pulsation heart auxiliary device. The characteristics of the aorta bypass counter-pulsation heart auxiliary device are as follows: the heart auxiliary device is embedded into a human body and is provided with a hollow main body cavity chamber, the main body cavity chamber is composed of a first inner cavity and a second inner cavity, a flexible diaphragm is arranged between the first inner cavity and the second inner cavity, the first inner cavity is provided with a clack-less opening which is communicated with an aorta by an artificial blood vessel, and the second inner cavity is provided with an air inlet/outlet which is connected with an air driving device by a pipeline. The beneficial effects of the aorta bypass counter-pulsation heart auxiliary device are as follows: aorta blood is absorbed into the device during systole, so as to lower the systolic pressure of the aorta, lessen after load of the heart, and reduce the myocardial oxygen consumption; the blood in the device is injected into a large blood vessel during diastole, so as to improve the diastolic pressure of the aorta, increase the perfusion of a crown artery and other tissues, and achieve the purpose of assisting the circulation.
Description
Technical field
This utility model patent belongs to the cardiac mechanical auxiliary device, a kind of effective circulation support that not only can provide is provided, and volume is little, implant easily, the patient does not need braking, has the large-artery side counterpulsation heart auxiliary device and the manufacture method of good organization's compatibility in heart failure patient prolonged application.
Background technology
According to statistics, in China adult, have and surpass 4,000,000 heart failure (annual medical expense has brought huge burden up to 10,000,000,000 yuans to the country and people for Heart failure, HF) patient.At present, can't obtain satisfied effect for severe and intractable HF Drug therapy; And heart transplantation is subjected to the donor restriction.So the cardiac mechanical auxiliary device progressively becomes effective Therapeutic Method of serious difficult treated HF.
The cardiac mechanical auxiliary device is by keeping effective circulation, reduce myocardial oxygen consumption, reduce myocardium cell necrosis, suppress remodeling ventricle, increase coronary perfusion, promoting cardiac muscle to recover, to reach the purpose of saving patient's life.Especially in ischemic severe HF patient, the myocardial oxygen consumption of attenuating can make the infarcted region edge be in the myocardial cell energy equilibrium of supply and demand of ischemic state, thereby reverses the damage of myocardial cell, promotes the recovery of its function.At present, it is more and more to break away from cardiopulmonary bypass unit and wait heart transplantation and heart disease at final stage people behind severe acute heart failure, the operation on heart, is badly in need of heart assistance short-term transition or keeps long period wait heart donor or long-term assisting.Therefore, require auxiliary device not only favorable durability will be arranged, and higher biocompatibility will be arranged.At present, axial flow blood pump and centrifugal blood pump can provide very effective circulation support, but the excessively hemorrhage and not enough thrombosis of anticoagulant in back of anticoagulant, fatal severe complications such as the auxiliary back of left heart right heart failure may appear in the patient.IABC (IABP) is because of implanting simple, safety, and is cheap, improves cardiac function by reducing afterload, becomes clinical the most frequently used circulatory aid.But in its application process, clinical discovery has following shortcoming: the hemodynamics that 1. provides is supported limited, the cardiac function of strong dependent patient self and playing a role; 2. can not prolonged application (generally in 2 weeks) because the restriction patient is movable; 3. complication such as IABP implantable intravascular far-end ischemia and thrombosis may take place.So, clinical demand urgently developing a kind ofly can provide effective circulation support, and the heart-assist device that volume is little, implants easily, the patient is movable and longer-term is used.
The utility model patent content
The purpose of this utility model is to overcome the deficiency of above-mentioned technology, a kind of large-artery side counterpulsation heart auxiliary device of using electrocardio or pressure activated gas-powered is provided, it is sutured in by the human body trunk, at paradoxical expansion the large artery trunks inner blood is sucked, reduce aortic systolic pressure, reduce cardiac afterload, reduce the heart acting, lower myocardial oxygen consumption; Diastole is squeezed into the blood in this device in the large artery trunks, to improve aortic diastolic pressure, increases the perfusion of arteria coronaria and surrounding tissue, improves cardiac function.
This utility model for achieving the above object, by the following technical solutions: a kind of large-artery side counterpulsation heart auxiliary device, it is characterized in that: it constitutes by inserting the main body chamber that has hollow in the body, the main body chamber is made up of first inner chamber and second inner chamber, be provided with barrier film between first and second inner chamber, first inner chamber is provided with no lobe opening, communicates with large artery trunks by the artificial blood vessel, second inner chamber is provided with air inlet/outlet, links to each other with gas actuating device by pipeline; The chamber inner wall of first inner chamber and membrane surface are equipped with the heparin layer of combination.
Described membrane surface under non-inflated state is provided with and is spiral helicine several gauffers of concentric circular dish-type, gauffer cross section indention.
Described first cavity volume is 20-120ml.
Described first inner chamber and barrier film join domain are all in obtuse angle.
The described first inner chamber fornix top is provided with circular button exhaust apparatus.
Described main cavity chamber outer wall is provided with the small embossment of several stationary body chambers.
Artificial blood vessel's diameter that described and first inner chamber does not have the lobe open communication is 4mm-14mm.
The artificial blood vessel that described and first inner chamber does not have the lobe open communication is fit to ascending aorta or descending aorta or subclavian artery or femoral artery or pulmonary artery trunk.
This utility model beneficial effect: it utilizes the anti-principle of fighting, using electrocardio or pressure waveform triggers, work asynchronously by gas-powered, this device is sutured in by the trunk, at paradoxical expansion the large artery trunks inner blood is sucked this device, reduce aortic systolic pressure, reduce cardiac afterload, reduce the heart acting, lower myocardial oxygen consumption; Diastole is squeezed into the blood in this device in the large artery trunks, to improve aortic diastolic pressure, increases the perfusion of arteria coronaria and surrounding tissue organ, and good assist circulation is improved the function of heart and each histoorgan of whole body.Still effective when the serious difficult treated heart failure, not only can being applied to the left heart, auxiliary can also to be applied to the right heart auxiliary; Its volume is little, implants easily, and the patient does not need braking, and histocompatibility obviously is better than other assist in prolonged application; Its available IABP main frame drives synchronous working by air pump.
Description of drawings
Fig. 1 is the structural representation under this utility model non-inflated state;
Fig. 2 is the structural representation under Fig. 1 inflated condition;
Fig. 3 is the vertical view of Fig. 1;
Fig. 4 is the sketch map that this utility model is inserted subclavian artery;
Fig. 5 is the sketch map that this utility model is inserted descending aorta.
Among the figure: 1, main body chamber, 2, first inner chamber, 3, second inner chamber, 4, barrier film, 4-1, gauffer, 4-2, obtuse angle, 5, no lobe opening, 6, the artificial blood vessel, 7, air inlet/outlet, 8, pipeline, 9, gas actuating device, 10, small embossment, 11, the heparin layer, 12, descending aorta, 13, subclavian artery 14, exhaust apparatus.
The specific embodiment
Describe the specific embodiment of this utility model patent in detail below in conjunction with accompanying drawing.
As shown in the figure, a kind of large-artery side counterpulsation heart auxiliary device, it constitutes by inserting the main body chamber 1 that has hollow in the body, described main body chamber is made up of first inner chamber 2 and second inner chamber 3, be provided with barrier film 4, the first inner chambers between first and second inner chamber and be provided with no lobe opening 5, communicate with large artery trunks by artificial blood vessel 6, second inner chamber is provided with air inlet/outlet 7, links to each other with gas actuating device 9 by pipeline 8.The inwall of first inner chamber and membrane surface are equipped with the heparin layer 11 of combination, can effectively prevent thrombosis.Under non-inflated state, described membrane surface is provided with and is spiral helicine several gauffers of concentric circular dish-type 4-1, and gauffer cross section indention to increase the barrier film mobility, improves pump blood efficient, makes blood in the first inner chamber rotational flow simultaneously, prevents thrombosis.The outdoor edge of described main cavity is provided with several small embossments that is used for fixing the main body chamber 10.Artificial blood vessel's diameter that described and first inner chamber does not have the lobe open communication is 4mm-14mm.The artificial blood vessel that described and first inner chamber does not have the lobe open communication is fit to ascending aorta or descending aorta 12 or subclavian artery 13 or femoral artery or pulmonary artery trunk.Described first inner chamber and barrier film join domain be 4-2 in obtuse angle all, and favourable blood better passes through, and eliminates the dead angle.The described first inner chamber fornix top is provided with circular button exhaust apparatus
To get rid of the first inner chamber gas inside.
The manufacture method of large-artery side counterpulsation heart auxiliary device, make according to the following steps:
(1), adopt conventional plastics vacuum casting film machine to make flexible first body wall, second body wall and flexible partition;
(2), the first interior cavity wall and flexible partition surface form organic bonded heparin layer: first inner chamber or membranous endosexine additional compound bottom form stable heparin layer by chemical bond between the ground floor and the second layer;
(3), use the radio-frequency welding machine and select for use 7.5 megahertz radio frequencies with first body wall, second body wall and be positioned at the two intermediary flexible partition periphery joint close welding, all soldereds are coated with and add sealer; Forming the main body chamber behind first body wall and the second body wall joint close, is first inner chamber between first body wall and the barrier film, is second inner chamber between the barrier film and second body wall;
(4), the no lobe opening welding of the artificial blood vessel and first body wall is fixing, the air inlet/outlet welding of breather line and second body wall is fixed;
(5), withstand voltage test: second body cavity when pressurization, can bear 13.8Kpa-20.7Kpa pressure, during the decompression of second body cavity, can bear-3.5Kpa is to the negative pressure of-41.4Kpa.
Operation principle: first inner chamber communicates with large artery trunks, and second inner chamber communicates with gas actuating device.During the second inner chamber aerofluxus, barrier film is shifted to second inner chamber, and first cavity volume increases, and sucks blood approximate first cavity volume of main body chamber volume during the barrier film maximum shift from large artery trunks; During the inflation of second inner chamber, barrier film is shifted to first inner chamber, and first cavity volume reduces, and blood is squeezed in the large artery trunks approximate second cavity volume of main body chamber volume during the barrier film maximum shift.Drive first inner chamber by barrier film and suck blood and penetrate blood, to reach the auxiliary purpose of circulation.Use electrocardio, pressure activated gas actuating device driving large-artery side counterpulsation heart auxiliary device synchronous working, at paradoxical expansion the large artery trunks inner blood is sucked this device, reduce aortic systolic pressure, reduce cardiac afterload, reduce the heart acting, lower myocardial oxygen consumption; Diastole is squeezed into the blood in this device in the large artery trunks, to improve aortic diastolic pressure, increases the perfusion of arteria coronaria and surrounding tissue organ, good assist circulation.This device not only can be placed on ascending aorta, descending aorta, subclavian artery and femoral artery, and can be positioned over main pulmonary artery, and is also applicable to pulmonary hypertension right heart failure patient.It can be applied to can not break away from cardiopulmonary bypass unit behind severe acute heart failure, the operation on heart, wait for heart transplantation and heart disease at final stage people.This device not only can be applied to the left heart, and auxiliary can also to be applied to the right heart auxiliary, and can be used as not only that short-term is auxiliary can also prolonged application.This device can pass through the blood vessel myometrial suture in the large artery trunks sidewall under non-extracorporeal circulation, make first inner chamber identical with blood, by sucking blood and penetrating blood, effectively assist circulation.Second inner chamber can be connected in gas actuating device by pipeline, as the IABP air pump, realizes and the heart driven in synchronism.
Animal experiment study: select 2 of 4 of adult sheep (40-52kg) and adult dogs (21-24kg) for use.In ascending aorta or the identical large-artery side counterpulsation heart auxiliary device (sheep is used 60ml, and dog is used 40ml) of descending aorta.Set up the acute heart failure model.Detect the auxiliary front and back of heart failure aortic pressure, left indoor pressure, pulmonary artery down pressure, cardiac output, carotid artery flow, coronary flow, crown arteriovenous blood oxygen saturation, calculate endocardium survival rate, left outdoor merit, myocardial oxygen consumption.The result: acute heart failure, large-artery side counterpulsation heart auxiliary device can provide tangible circulation support.After auxiliary, aortic systolic pressure obviously descends, and aortic diastolic pressure significantly improves, and coronary flow increases by 50%, the ventricular systole drops, and the heart acting reduces, and cardiac output increases.Simultaneously, the carotid artery flow amount increases near 1 times, and the Coronary vein blood oxygen saturation brings up to 60.9% from 20.8%, and the endocardium survival rate is increased to 2.30 by 0.62, and left outdoor merit reduces by 16.3%, and myocardial oxygen consumption reduces by 15.1%.Conclusion: large-artery side counterpulsation heart auxiliary device lowers cardiac afterload by reducing aortic systolic pressure, increases cardiac output, reduce the heart acting simultaneously, reduce myocardial oxygen consumption, increase the relaxing period perfusion, the heart failure animal, can keep effective circulation, improve cardiac function.
The above only is the preferred embodiment of this utility model patent, is not the structure of this utility model patent is done any pro forma restriction.Every technical spirit according to this utility model patent all still belongs to the scope of the technical scheme of this utility model patent to any simple modification, equivalent variations and modification that above embodiment did.
Claims (8)
1, a kind of large-artery side counterpulsation heart auxiliary device, it is characterized in that: it is made of the main body chamber of inserting intravital hollow, the main body chamber is made up of first inner chamber and second inner chamber, be provided with barrier film in the middle of two chambers, first inner chamber is provided with no lobe opening, communicate with large artery trunks by the artificial blood vessel, second inner chamber is provided with air inlet/outlet, links to each other with gas actuating device by pipeline; Cavity wall and flexible partition surface forms the heparin layer that one deck organically combines in first.
2, large-artery side counterpulsation heart auxiliary device according to claim 1 is characterized in that: described membrane surface has in non-inflated state and is spiral helicine several gauffers of concentrically ringed dish-type, gauffer cross section indention.
3, large-artery side counterpulsation heart auxiliary device according to claim 1 is characterized in that: described first cavity volume is 20-120ml.
4, large-artery side counterpulsation heart auxiliary device according to claim 1 is characterized in that: artificial blood vessel's diameter that described and first inner chamber does not have the lobe open communication is 4mm-14mm.
5, large-artery side counterpulsation heart auxiliary device according to claim 1 is characterized in that: described first inner chamber and barrier film join domain are all in obtuse angle.
6, large-artery side counterpulsation heart auxiliary device according to claim 1 is characterized in that: the described first inner chamber fornix top is provided with circular button exhaust apparatus.
7, large-artery side counterpulsation heart auxiliary device according to claim 1 is characterized in that: described main cavity chamber outer wall is provided with some small embossments that are used for fixing the main body chamber.
8, large-artery side counterpulsation heart auxiliary device according to claim 1 is characterized in that: the artificial blood vessel that described and first inner chamber does not have the lobe open communication is fit to ascending aorta or descending aorta or subclavian artery or femoral artery or pulmonary artery trunk.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN200920095633U CN201375702Y (en) | 2009-02-24 | 2009-02-24 | Aorta bypass counter-pulsation heart auxiliary device |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN200920095633U CN201375702Y (en) | 2009-02-24 | 2009-02-24 | Aorta bypass counter-pulsation heart auxiliary device |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN201375702Y true CN201375702Y (en) | 2010-01-06 |
Family
ID=41515796
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN200920095633U Expired - Lifetime CN201375702Y (en) | 2009-02-24 | 2009-02-24 | Aorta bypass counter-pulsation heart auxiliary device |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN201375702Y (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN110975113A (en) * | 2019-12-23 | 2020-04-10 | 张杰民 | Minimally invasive path and implantation method of extra-corporeal blood pump aortic counterpulsation circulation auxiliary device |
| CN111298225A (en) * | 2019-12-02 | 2020-06-19 | 李勇 | Balloon heart counterpulsation device comprising electromagnet |
-
2009
- 2009-02-24 CN CN200920095633U patent/CN201375702Y/en not_active Expired - Lifetime
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN111298225A (en) * | 2019-12-02 | 2020-06-19 | 李勇 | Balloon heart counterpulsation device comprising electromagnet |
| CN110975113A (en) * | 2019-12-23 | 2020-04-10 | 张杰民 | Minimally invasive path and implantation method of extra-corporeal blood pump aortic counterpulsation circulation auxiliary device |
| CN110975113B (en) * | 2019-12-23 | 2022-02-15 | 张杰民 | Counterpulsation pump pipeline of external blood pump aorta counterpulsation circulation auxiliary device |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US7357771B2 (en) | Heart assist devices, systems and methods | |
| US6945998B2 (en) | Corporal implantation device for assisting blood and heart ventricular circulation | |
| US7273446B2 (en) | Methods, devices and systems for counterpulsation of blood flow to and from the circulatory system | |
| US20070208210A1 (en) | Method and apparatus to unload a failing heart | |
| US20060199993A1 (en) | Devices and methods for blood flow assistance | |
| CN104146855A (en) | Heart auxiliary device | |
| CN201375702Y (en) | Aorta bypass counter-pulsation heart auxiliary device | |
| CN108310497B (en) | Minimally invasive catheter type synchronous heart auxiliary device and application method thereof | |
| CN101491706A (en) | Large-artery side counterpulsation heart auxiliary device and production method thereof | |
| Kung et al. | Heart booster: a pericardial support device | |
| WO2018177342A1 (en) | Cystic cavopulmonary device for assisted circulation | |
| Capoccia et al. | Evidence of clinical efficacy of counterpulsation therapy methods | |
| CN201727777U (en) | External assisting device of cardiac counterpulsation beside main artery | |
| CN201727776U (en) | Heart auxiliary capacity expander | |
| CN203852643U (en) | Integrated manometry external paraaortic counterpulsation heart assisting device | |
| CN201572358U (en) | Cardiac impulse assisting device and cardiac impulse assisting system | |
| US11241571B2 (en) | Implantable ventricular assist device | |
| CN101862480B (en) | Cardiac auxiliary volume amplifier | |
| CN103977462A (en) | Pressure measuring integrated external counterpulsation heart auxiliary device beside main artery | |
| CN204033740U (en) | Heart-assist device | |
| CN219071821U (en) | Left ventricle blood pumping device | |
| CN211157660U (en) | Refractory heart failure left ventricle function auxiliary device | |
| CN106310411A (en) | Ascending aorta type ventricular assisting device | |
| Nojiri et al. | Small soft left ventricular assist device powered by intraaortic balloon pump console for infants: a less expensive option | |
| AU2006200168B2 (en) | Heart assist devices, systems and methods |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CX01 | Expiry of patent term | ||
| CX01 | Expiry of patent term |
Granted publication date: 20100106 |